BG60980B2 - Чиста кристална форма на рифапентин - Google Patents

Чиста кристална форма на рифапентин Download PDF

Info

Publication number
BG60980B2
BG60980B2 BG098539A BG9853994A BG60980B2 BG 60980 B2 BG60980 B2 BG 60980B2 BG 098539 A BG098539 A BG 098539A BG 9853994 A BG9853994 A BG 9853994A BG 60980 B2 BG60980 B2 BG 60980B2
Authority
BG
Bulgaria
Prior art keywords
rifapentine
water
rifapentin
crystalline form
pure crystalline
Prior art date
Application number
BG098539A
Other languages
Bulgarian (bg)
English (en)
Inventor
Marino Nebuloni
Emilio Occelli
Bruno Cavalleri
Original Assignee
Sanofi Aventis S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis S.P.A. filed Critical Sanofi Aventis S.P.A.
Publication of BG60980B2 publication Critical patent/BG60980B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
BG098539A 1990-06-29 1994-02-24 Чиста кристална форма на рифапентин BG60980B2 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90112458 1990-06-29
PCT/EP1991/001036 WO1992000302A1 (fr) 1990-06-29 1991-06-05 Rifapentine sous forme cristalline pure

Publications (1)

Publication Number Publication Date
BG60980B2 true BG60980B2 (bg) 1996-07-31

Family

ID=8204159

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098539A BG60980B2 (bg) 1990-06-29 1994-02-24 Чиста кристална форма на рифапентин

Country Status (12)

Country Link
EP (1) EP0536197B1 (fr)
JP (1) JP3350861B2 (fr)
KR (1) KR0170000B1 (fr)
AT (1) ATE125541T1 (fr)
BG (1) BG60980B2 (fr)
CA (1) CA2082809C (fr)
DE (1) DE69111607T2 (fr)
DK (1) DK0536197T3 (fr)
ES (1) ES2075454T3 (fr)
HU (1) HU211168A9 (fr)
IE (1) IE68687B1 (fr)
WO (1) WO1992000302A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1279898B1 (fr) 2001-07-26 2008-09-10 ALSTOM Technology Ltd Brûleur à prémélange offrant une haute stabilité de flamme
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7262236B2 (en) 2004-04-26 2007-08-28 Milliken & Company Acetal-based compositions
PT1698630E (pt) * 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
IT1397107B1 (it) * 2009-12-28 2012-12-28 Lavagna Nuovo metodo per la preparazione di antibiotici in stato amorfo e prodotti ottenuti utilizzando detto metodo.
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CN102079749B (zh) * 2010-11-25 2012-07-04 河北欣港药业有限公司 利福平原料药≤0.3g/ml及≥0.8g/ml密度规格的生产方法
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
CN103772413B (zh) * 2014-02-07 2016-01-20 天津大学 一种利福平ⅱ晶型的制备方法
WO2022225384A1 (fr) * 2021-04-21 2022-10-27 Interquim, S.A. De C.V. Procédé d'obtention de rifapentine avec une nouvelle forme cristalline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides

Also Published As

Publication number Publication date
ATE125541T1 (de) 1995-08-15
IE912266A1 (en) 1992-01-01
CA2082809C (fr) 1995-10-17
DE69111607D1 (de) 1995-08-31
KR0170000B1 (ko) 1999-02-01
ES2075454T3 (es) 1995-10-01
JPH05507690A (ja) 1993-11-04
JP3350861B2 (ja) 2002-11-25
HU211168A9 (en) 1995-11-28
DK0536197T3 (da) 1995-11-13
HK1005454A1 (en) 1999-01-08
WO1992000302A1 (fr) 1992-01-09
EP0536197B1 (fr) 1995-07-26
IE68687B1 (en) 1996-07-10
EP0536197A1 (fr) 1993-04-14
KR930701448A (ko) 1993-06-11
DE69111607T2 (de) 1995-12-21

Similar Documents

Publication Publication Date Title
US5463116A (en) Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
EP0526171B1 (fr) Cristaux de N-(trans-4-isopropylcyclohexylcarbonyl)-D-phénylalanine et procédés pour leur préparation
EP2548879B1 (fr) Cristal de dérivé de diamine et sa méthode de production
JP3726291B2 (ja) 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
KR100588254B1 (ko) 결정 형태의ｎ-(4-트리플루오로메틸페닐)-5-메틸이속사졸-4-카복스아미드
JP3350861B2 (ja) リファペンチンの純粋の結晶型
EP3656768A1 (fr) Cristaux de beraprost-314d et méthodes pour leur préparation
CA3181665A1 (fr) Formes cristallines d'acide acetique {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl} et leurs utilisations
HK74494A (en) Pharmaceutically useful polymorphic modification of buspirone
CN114409665A (zh) 螺-吲哚酮化合物的固态形式
KR100535305B1 (ko) 토실산 스프라타스트 결정
TWI680983B (zh) 一種鈉－葡萄糖共同轉運蛋白２抑制劑的ｌ－脯胺酸複合物、其一水合物及晶體
UA74003C2 (en) Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, a process for preparing thereof and a pharmaceutical composition
EP1777217B1 (fr) Procédé d'évaluation de la régularité de cristaux de tosilate suplatast, cristaux réguliers et procédé de fabrication desdits cristaux
DE60129576T2 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
EP3034496A1 (fr) Nouveaux solvates de n-[2-[(1s)-1-(3-ethoxy-4-méthoxyphényl)-2-(méthylsulfonyl)éthyl]-2,3-dihydro-1,3-dioxo-1h-isoindol-4-yl] acétamide
US20240199642A1 (en) Method for obtaining rifapentine with a new crystalline form
EP2280980B1 (fr) Forme cristalline de n-[[4-fluoro-2-(5-méthyl-1h-1,2,4-triazol-1-yl)phényl]méthyl]-4,6,7,9-tétrahydro-3-hydroxy-9,9-diméthyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sel de sodium monohydrate
HUE025398T2 (en) New crystalline modification of CDB-4124
HK1005454B (en) Pure crystalline form of rifapentine
HK40069266A (en) Solid state forms of spiro-oxindole compounds
EA004298B1 (ru) Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата
BG107679A (bg) Натриеви соли на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
JPH0753490A (ja) ベザフィブレートの新規で安定な結晶形
SK287243B6 (sk) Soľ 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoxy]benzyl]thiazolidín- 2,4-diónu a kyseliny L (+) vínnej, spôsob jej prípravy a použitie, farmaceutická kompozícia s jej obsahom